Results 31 to 40 of about 33,753 (206)
Biomarkers in acute coronary syndromes and their role in diabetic patients [PDF]
Diabetic patients with acute coronary syndromes are at high risk for cardiovascular complications but risk stratification in these patients remains challenging.
Heeschen, Christopher
core +1 more source
Background: Coronary microvascular dysfunction after acute coronary syndrome is an important predictor of long-term prognosis. Data is lacking on the effects of oral P2Y12-inhibitors on coronary microvascular function in non-ST-segment-elevation acute ...
Mussap, Christian J. +9 more
core +1 more source
The Myocardial Ischaemia National Audit Project (MINAP). [PDF]
UNLABELLED: AIMS OF MINAP: To audit the quality of care of patients with acute coronary syndrome and provide a resource for academic research. QUALITY OF CARE INTERVENTIONS: Feedback to hospitals, ambulance services and cardiac networks regarding ...
Clive Weston +12 more
core +1 more source
Rationale: Dual antiplatelet therapy, consisting of aspirin and a P2Y12-inhibitor, reduces the risk of stent thrombosis, myocardial infarction and stroke after coronary stent implantation.
N.M.R. van der Sangen (11844380)
core +1 more source
Altered gene expression pattern in peripheral blood mononuclear cells in patients with acute myocardial infarction. [PDF]
In the acute phase of STEMI, dozens of genes from several pathways linked with lipid/glucose metabolism, platelet function and atherosclerotic plaque stability show altered expression.
Burzynska, Beata +29 more
core +1 more source
Background: Readmissions following acute coronary syndrome are unevenly distributed across the 30-day post-discharge period. There is limited data on predictors of all-cause readmission in early (0-7 day) and late (8-30 day) post-discharge periods for ...
George Cholack +9 more
doaj +1 more source
Timing of coronary angioplasty in patients with non-ST-segment elevation acute coronary syndromes [PDF]
This editorial refers to ‘Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study’, by Lindholm et al. doi:10.1093/ehjqcco/qcw044 ‘ Never leave that till tomorrow which you can do today.
Jubin P, Joseph, Simon R, Redwood
openaire +2 more sources
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. [PDF]
An issue, which is not addressed by the guidelines, is whether, in the absence of Sgarbossa's criteria, the association of acute coronary syndrome (ACS) type chest pain1 and left bundle branch block (LBBB) falls within the province of non-ST segment elevation ACS (nSTE-ACS) or whether it falls within the province of acute myocardial infarction ...
Jean-Pierre, Bassand +10 more
openaire +5 more sources
Introduction: Acute coronary syndrome remains the leading cause of morbidity and mortality worldwide. It will continue to rise as the prevalence of patients with obesity and diabetes increases.
Ashraf Hussien +3 more
doaj +1 more source
The published version of the aritcle can be found at the link below.Background: Evidence suggests that an early interventional strategy for patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) can improve health outcomes but also increase ...
Sculpher, Mark, +17 more
core +1 more source

